L-Thyroxine-13C9,15N Chemical Properties

storage temp. 

Store at -20°C

solubility 

DMF: 0.14 mg/ml; DMSO: 2.5 mg/ml; DMSO:PBS (pH 7.2) (1:1): 0.50 mg/ml

form 

A solid

L-Thyroxine-13C9,15N Usage And Synthesis

Description

L-Thyroxine-¹³C₉,¹⁵N is intended for use as an internal standard for the quantification of L-thyroxine by GC- or LC-MS. L-Thyroxine is a synthetic form of the thyroid hormone thyroxine. In vivo, L-thyroxine (0.9 and 2.7 μg) inhibits synthesis and release of thyrotropin induced by thyrotropin-releasing hormone from the anterior pituitary in mice. It also reverses decreases in levels of circulating thymic serum factor (FTS) and the number of T rosette-forming cells in an old age-induced mouse model of hypothyroidism. Formulations containing L-thyroxine have been used in the treatment of hypothyroidism.

Uses

Thyroxine Carboxy,α,β,1,2,3,4,5,6-13C9,15N is 13C and 15N labeled analogue of Thyroxine (T425600), which is one of the thyroid hormones involved in the maintenance of metabolic homeostasis.

L-Thyroxine-13C9,15N(1431868-11-9)Related Product Information

• Levothyroxine Impurity
• (2S,2''S)-3,3''-(((6,6''-Dihydroxy-5-iodo-[1,1''-biphenyl]-3,3''-diyl)bis(oxy))bis(3,5-diiodo-4,1-phenylene))bis(2-aminopropanoic Acid)
• Levothyroxine Impurity 12
• Levothyroxine Impurity 16
• Levothyroxine EP Impurity B
• Levothyroxine Related Compound (2-Acetamido-3-(4-acetoxy-3,5-diiodophenyl)propanoic Acid)
• 3-Iodo-DL-tyrosine
• 3,5-DIIODOTHYROACETIC ACID
• Levothyroxine Impurity
• Levosimendan Impurity 8
• Levothyroxine Impurity 54
• Levothyroxine Impurity
• Levothyroxine Related Compound (2-Acetamido-3-(3,5-diiodo-4-(4-methoxyphenoxy)phenyl) Propanoic Acid)
• 3,3',5-TRIIODOTHYROPROPIONIC ACID
• Levothyroxine Impurity 16
• (S)-2-(2-Amino-3-(4-(3,5-diiodo-4-methoxyphenoxy)-3,5-diiodophenyl)propanamido)acetic Acid
• α-Hydroxy-4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodo-N-methyl-benzeneacetamide
• Levothyroxine Impurity